Showing results (4921-4930 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|May 28, 2013
The NOMS framework: approach to the treatment of spinal metastatic tumorsIlya Laufer, David G Rubin, Eric Lis, et al.The Oncologist|May 28, 2013
Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumorsPiotr Rutkowski, Alessandro GronchiThe Oncologist|July 13, 2013
AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumorsElizabeth R Plimack, Patricia M Lorusso, Patricia McCoon, et al.The Oncologist|July 13, 2013
Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancerRavi A Madan, Kwong-Yok Tsang, Marijo Bilusic, et al.The Oncologist|July 16, 2013
Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of βIII-tubulin expression as a predictive markerCristina Saura, Ling-Ming Tseng, Stephen Chan, et al.The Oncologist|July 23, 2013
Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programsBernardo H L Goulart, Scott D RamseyThe Oncologist|August 14, 2013
Dose-dense FEC followed by dose-dense ixabepilone as neoadjuvant treatment for breast cancer patients: a feasibility studyMatteo Clavarezza, Roberto Bordonaro, Bruno Daniele, et al.The Oncologist|September 17, 2013
PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?Jessica L Mester, Rebekah A Moore, Charis EngThe Oncologist|September 17, 2013
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neckLale Kostakoglu, Reza Fardanesh, Marshall Posner, et al.The Oncologist|September 17, 2013
Current understanding and management of medullary thyroid cancerMadhuchhanda Roy, Herbert Chen, Rebecca S SippelPageof 571